Navigation Links
Pipeline Insight: Gastrointestinal Cancer Overview - Metastatic Gastrointestinal Cancers Represent a Significant Commercial Opportunity Due to a Lack of Approved Drugs
Date:11/4/2010

e shown encouraging survival results associated with Avastin, however, the risk of gastrointestinal perforations and bleeding remains a major concern 110

SWOT analysis 111

Datamonitor drug assessment scorecard for Avastin 112

Clinical and commercial attractiveness 113

Failure of the Phase III AVAGAST study to meet its primary endpoints in first-line metastatic gastric cancer is a setback... 113

...although Avastin could still have a role in resectable gastric cancer 114

Roche's leading position in the oncology market will almost certainly result in success 114

Increasingly cost-conservative healthcare systems could restrict potential uptake of Avastin 114

Satisfaction of unmet needs 115

Forecasts to 2019 115

Erbitux (cetuximab; Eli Lilly/Bristol-Myers Squibb/Merck KGaA) 116

Drug overview 116

Drug profile 116

Key historical events 117

Clinical trial data 118

Several Phase II studies have shown encouraging survival results associated with Erbitux, with a potential tumor response correlation linked to incidence of acneiform rash 119

SWOT analysis 120

Datamonitor drug assessment scorecard for Erbitux 121

Clinical and commercial attractiveness 122

Phase II data show a comparable response rate to the current first-line standard, but the Phase III EXPAND trial will need to demonstrate superior overall survival 122

Erbitux's cost may hinder its uptake in certain markets... 122

...although if use is targeted to specific patient subtypes, then the issue of cost may be overcome 123

Satisfaction of unmet needs 123

Forecasts to 2019 124

Afinitor (everolimus; Novartis) 125

Drug overview 125

Drug profile 125

Key historical events 126

Clinical trial data 127

Phase II results showed 0% overall response rate, but a very encouraging median overall survival of 10.1 months in heavily pre
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Karyopharm Therapeutics Inc. Closes $20 Million Series A Financing to Advance Pipeline of Novel Nuclear Transport Modulators for Cancer, Inflammation and Other Disorders
2. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
3. Lexicon to Provide Clinical Pipeline Update and Report Third Quarter 2010 Financial Results
4. Reportlinker Adds Commercializing Cancer Vaccines: A Decision Support Tool for Optimizing the Pipeline
5. Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports
6. Updated Pfizer Pipeline Focuses on Value, Unmet Medical Need
7. Reportlinker Adds Electrophysiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
8. Reportlinker Adds Prosthetic Heart Valves - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
9. Abbott to Present Data on Market-Leading XIENCE V® and Promising Vascular Pipeline at TCT 2010
10. Reportlinker Adds Interventional Cardiology Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
11. Reportlinker Adds Global Renal Dialysis Equipment Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2014)... , Dec. 12, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/ms3j8c/cardiac ) has announced the addition ... and Forecasts, 2012-2018"  report to their offering. Global ... 2016. The North America accounts ... Europe claims approximately 25% (2018). ...
(Date:12/15/2014)... and BRIDGEWATER, N.J. , Dec. ... and Sanofi US (EURONEXT: SAN and NYSE: SNY) are ... to launch Cholesterol Counts , an awareness program ... their numbers, and the risks associated with high LDL-C ... www. CholesterolCounts .com to take a brief poll ...
(Date:12/15/2014)... SAN MARCOS, Texas , Dec. 15, 2014 /PRNewswire/ ... quantum dot manufacturer Quantum Materials Corp (OTCQB:QTMM), ... Rice Center for Quantum Materials (RCQM) on December 16th, ... the exploration of exotic nanomaterials in attracting top faculty ... to Rice to collaborate on research. ...
Breaking Medicine Technology:Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 2Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 3Cardiac Guidewires - Global Trends, Estimates and Forecasts, 2012-2018 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 2Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 3Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 4Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 5Have You Been Counted? Regeneron and Sanofi US Join Forces with Leading Cardiovascular Organizations to Raise Awareness of Cholesterol 6Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 2Quantum Materials CEO Stephen Squires to Speak at Rice Center for Quantum Materials Launch 3
(Date:12/17/2014)... HealthDay Reporter , TUESDAY, Dec. 16, 2014 (HealthDay ... work commitment is a big reason why, new research suggests. ... Mathias Basner, an assistant professor of sleep and chronobiology in ... A time-use survey of nearly 125,000 Americans, ages 15 ... exchanged for sleep. Short sleepers -- those who slept six ...
(Date:12/15/2014)... Street Dental Team ( http://www.MainStreetDentalTeam.com ), Unionville’s first full-time ... providing evidence on the impact of 100% pure fruit ... enough evidence already exists showing a negative link between ... the onset of tooth decay. One question that has ... fruit juice, meaning it is completely natural with no ...
(Date:12/15/2014)... Health Dialog, a leading provider ... it has received Patient Oriented Accreditation from the ... Disease Management (DM) Programs for asthma, congestive heart ... disease and diabetes. This marks the 12th continuous ... Disease Management (DM) Programs, reaffirming Health Dialog’s focus ...
(Date:12/15/2014)... 15, 2014 Kathy McAfee, America's Marketing ... World Awards in the category of Best Blog 2014. ... for her weekly career blog Networking Ahead ... help professionals elevate their talent and influence through better ... after her book Networking Ahead for Business, has been ...
(Date:12/15/2014)... Ontario (PRWEB) December 15, 2014 Bacteroides is ... Not only is it much more prevalent than coliforms, it ... replicate in the environment. , Key Benefits of the ... for fecal contamination , Eliminates false positives from ... Specificity and Sensitivity , Maintain the same ...
Breaking Medicine News(10 mins):Health News:Work Steals Valuable Sleep Time, Study Finds 2Health News:Work Steals Valuable Sleep Time, Study Finds 3Health News:Main Street Dental Team, Unionville’s Most Innovative Dental Clinic, Comments on New Study Relating Pure Fruit Juice to Poor Oral Hygiene 2Health News:Health Dialog Receives NCQA Accreditation for Disease Management Programs 2Health News:Kathy McAfee, America’s Marketing Motivator, Wins Best Blog from Women World Awards 2
... N.C., Feb. 5 Many leading companies have ... various reasons, but in times of economic adversity, ... functions within companies are being questioned. Although internal ... purpose, these organizations often grow and take on ...
... Republic of The Gambia has decided to create a ... (Iniciaci sense mutilaci), directed by UAB researcher Adriana Kaplan, ... Institute of Primary Care Research IDIAP Jordi Gol and ... eliminate the genital lesions created by these traditional rituals ...
... (CMC) has,selected Surgical Information Systems (SIS) to be ... in Scranton, PA. , ... CMC chose the SIS Solution ... and operational efficiencies in the surgery department.,In addition ...
... Minutes Without Side Effects or PillsPHOENIX and SCOTTSDALE, ... specialist Morton I. Hyson, M.D., will announce a ... according to Clinical Topicals PHP. The treatment works ... or contraindications ( www.HysonHeadache.com ). After a decade ...
... preventing cystic fibrosis lung disease in an animal model by ... the first therapy to successfully attack the root cause of ... mice are given inhalation treatment with the drug in the ... lungs and airway inflammation and chronic lung damage can be ...
... Barcode Point-of-Care Patient Safety Solution-SAN DIEGO, Feb. 5 ... barcode point-of-care (BPOC) solutions to hospitals, today announced ... is now being used by 55 U.S. hospitals. ... to go live with the IntelliDOT System on January ...
Cached Medicine News:Health News:New Study Provides Benchmarks for Best Practices for Valuing Internal Consulting Organizations 2Health News:Gambia takes on as National Program UAB project to abolish FGM 2Health News:Gambia takes on as National Program UAB project to abolish FGM 3Health News:Community Medical Center (Scranton) Selects SIS Perioperative Solution 2Health News:Neurologist to Announce Breakthrough Headache Treatment 2Health News:Hope for preventative treatment for cystic fibrosis lung disease 2Health News:Hope for preventative treatment for cystic fibrosis lung disease 3Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 2Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 3Health News:IntelliDOT Bedside Medication Administration(TM) Goes Live at 55th Hospital 4
... model CC4204BF, is a single ... the capsular bag. The lens ... post-operative fixation. The light patterns ... are nearly identical to those ...
The STAAR ELASTIMIDE™ lens, combines the best of foldable lens technology with traditional design. This lens contains a cast-molded, silicone optic with modified Polyimide haptics....
... at Pfizer used wavefront sensing to invent ... Innovative TECNIS features a patented modified prolate ... which compensates for the positive spherical aberration ... is the first and only IOL with ...
Multi piece lens, AC depth: 4.2....
Medicine Products: